|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-6
|
|
pubmed:abstractText |
Ergot-derived dopamine agonists are associated with increased risk of valvular dysfunction in Parkinson's disease. The risk of valvular disease associated with lower doses of cabergoline used to treat prolactinomas remains controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1365-2265
|
|
pubmed:author |
pubmed-author:BillerBeverly M KBM,
pubmed-author:GrinspoonStevenS,
pubmed-author:JalceRR,
pubmed-author:KlibanskiAnneA,
pubmed-author:LawsonElizabeth AEA,
pubmed-author:McCartyDavidD,
pubmed-author:MillerKaren KKK,
pubmed-author:NachtigallLisa BLB,
pubmed-author:PasseriJonathanJ,
pubmed-author:UtzAndreaA,
pubmed-author:ValassiElenaE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
53-8
|
|
pubmed:dateRevised |
2011-8-25
|
|
pubmed:meshHeading |
pubmed-meshheading:19508591-Adult,
pubmed-meshheading:19508591-Aged,
pubmed-meshheading:19508591-Aged, 80 and over,
pubmed-meshheading:19508591-Antineoplastic Agents,
pubmed-meshheading:19508591-Case-Control Studies,
pubmed-meshheading:19508591-Echocardiography,
pubmed-meshheading:19508591-Ergolines,
pubmed-meshheading:19508591-Female,
pubmed-meshheading:19508591-Heart Valves,
pubmed-meshheading:19508591-Hormone Antagonists,
pubmed-meshheading:19508591-Humans,
pubmed-meshheading:19508591-Hyperprolactinemia,
pubmed-meshheading:19508591-Male,
pubmed-meshheading:19508591-Middle Aged,
pubmed-meshheading:19508591-Pituitary Neoplasms,
pubmed-meshheading:19508591-Prolactin,
pubmed-meshheading:19508591-Prolactinoma,
pubmed-meshheading:19508591-Retrospective Studies,
pubmed-meshheading:19508591-Sex Characteristics,
pubmed-meshheading:19508591-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study.
|
|
pubmed:affiliation |
Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. lnachtigall@partners.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
